Skip to main content
. Author manuscript; available in PMC: 2016 Jan 11.
Published in final edited form as: Angew Chem Int Ed Engl. 2014 Jan 20;53(7):1997–2001. doi: 10.1002/anie.201309985

Figure 4.

Figure 4

Effect of the targeted anti-MDR1 nanocomplexes on sensitivity of OVCAR8/ADR cells to doxorubicin: OVCAR8 cells (red), OVCAR8/ADR cells without (black) and with targeted nanocomplex treatment of 0.01 nM (blue), 0.04 (green) and 0.12 nM (pink). Each point represents the average value from three independent experiments.